BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17722971)

  • 1. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.
    Watkins PB; Dube LM; Walton-Bowen K; Cameron CM; Kasten LE
    Drug Saf; 2007; 30(9):805-15. PubMed ID: 17722971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and clinical efficacy of zileuton in patients with chronic asthma.
    Lazarus SC; Lee T; Kemp JP; Wenzel S; Dubé LM; Ochs RF; Carpentier PJ; Lancaster JF
    Am J Manag Care; 1998 Jun; 4(6):841-8. PubMed ID: 10181070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: a 6-month randomized controlled study.
    Wenzel S; Busse W; Calhoun W; Panettieri R; Peters-Golden M; Dube L; Walton-Bowen K; Russell H; Harris J
    J Asthma; 2007 May; 44(4):305-10. PubMed ID: 17530530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
    Israel E; Cohn J; Dubé L; Drazen JM
    JAMA; 1996 Mar; 275(12):931-6. PubMed ID: 8598621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
    Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
    Drug Saf; 2018 Jun; 41(6):625-640. PubMed ID: 29492878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
    Liu MC; Dubé LM; Lancaster J
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
    DuBuske LM; Grossman J; Dubé LM; Swanson LJ; Lancaster JF
    Am J Manag Care; 1997 Apr; 3(4):633-40. PubMed ID: 10169531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
    Tweed CD; Wills GH; Crook AM; Dawson R; Diacon AH; Louw CE; McHugh TD; Mendel C; Meredith S; Mohapi L; Murphy ME; Murray S; Murthy S; Nunn AJ; Phillips PPJ; Singh K; Spigelman M; Gillespie SH
    BMC Med; 2018 Mar; 16(1):46. PubMed ID: 29592805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.
    Watkins PB; Zimmerman HJ; Knapp MJ; Gracon SI; Lewis KW
    JAMA; 1994 Apr; 271(13):992-8. PubMed ID: 8139084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease.
    Weil JG; Bains C; Linke A; Clark DW; Stirnadel HA; Hunt CM
    Regul Toxicol Pharmacol; 2008 Nov; 52(2):85-8. PubMed ID: 18585425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery.
    Watkins PB; Desai M; Berkowitz SD; Peters G; Horsmans Y; Larrey D; Maddrey W
    Drug Saf; 2011 Mar; 34(3):243-52. PubMed ID: 21332248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results from a 2-year centralized tolcapone liver enzyme monitoring program.
    Lew MF; Kricorian G
    Clin Neuropharmacol; 2007; 30(5):281-6. PubMed ID: 17909306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.
    Tolman KG; Freston JW; Kupfer S; Perez A
    Drug Saf; 2009; 32(9):787-800. PubMed ID: 19670918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Adaptation to Therapeutic Doses of Acetaminophen: An Exploratory Study in Healthy Individuals.
    Maeda M; Tanaka R; Aso M; Sakamoto Y; Song I; Ochiai M; Saito Y; Maekawa K; Arakawa N; Ohno Y; Kumagai Y
    Clin Ther; 2020 Jul; 42(7):1276-1291.e1. PubMed ID: 32620339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic findings in long-term clinical trials of ximelagatran.
    Lee WM; Larrey D; Olsson R; Lewis JH; Keisu M; Auclert L; Sheth S
    Drug Saf; 2005; 28(4):351-70. PubMed ID: 15783243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations.
    Lin X; Parks D; Painter J; Hunt CM; Stirnadel-Farrant HA; Cheng J; Menius A; Lee K
    Drug Saf; 2012 Oct; 35(10):865-75. PubMed ID: 22928730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials.
    Kuffner EK; Temple AR; Cooper KM; Baggish JS; Parenti DL
    Curr Med Res Opin; 2006 Nov; 22(11):2137-48. PubMed ID: 17076974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.